Comments

Cidara Therapeutics Insider Trading Activity

CDTXNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$220.13

0.030.01%

Last update: Dec 16, 10:26 AM

Overview News Earnings Options Analyst Ratings

Insider Trades

Short Interest Stock Report

Cidara Therapeutics Insider Trading Activity | NASDAQ:CDTX | Benzinga

Track the latest Cidara Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Cidara Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Cidara Therapeutics Inc Insiders Doing?

At Cidara Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 15.04K shares worth $5.31M, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

On December 12, 2025, Shane Ward, the company's COO & CLO sold 15.04K shares for $119.37 each.

Ownership Statistics for Cidara Therapeutics Inc

Shares Outstanding

31.446M

Insider Shares Owned

1.353M

Insider Percentage Owned

4.30%

Institutional Shares Held

7.329M

Institutional Percentage Held

23.3%


Dec 12, 2025	Shane Ward	COO & CLO	-15.04K	$119.37	-$5.31M	SELL	-37.53%	25.03K	Dec 10	View
Sep 15, 2025	Negar Nicole Davarpanah	CHIEF MEDICAL OFFICER	-474.00	$62.86	-$29.80K	SELL	-1.49%	31.42K	Sep 11	View
Jun 30, 2025	RA CAPITAL MANAGEMENT LP RA Capital Healthcare Fund LP Peter Kolchinsky Rajeev Shah	DIRECTOR	2.27M	$44.00	$100.00M	BUY	207.97%	3.37M	Jun 26	View
Jun 04, 2025	Chrysa Mineo	DIRECTOR	3.32K	$22.26	$73.90K	BUY	∞	3.32K	Jun 02 - Jun 03	View
Mar 13, 2025	Shane Ward	COO & CLO	-1.66K	$21.96	-$36.54K	SELL	-10.18%	14.67K	Mar 11	View
Mar 13, 2025	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-1.77K	$21.96	-$38.94K	SELL	-9.82%	16.29K	Mar 11	View
Sep 13, 2024	Taylor Sandison	CHIEF MEDICAL OFFICER	-924.00	$11.64	-$10.75K	SELL	-3.85%	23.07K	Sep 11	View
Sep 13, 2024	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-909.00	$11.64	-$10.58K	SELL	-4.84%	17.86K	Sep 11	View
Jun 11, 2024	Jeffrey Stein	PRESIDENT & CEO	8.00K	$13.21	$105.68K	BUY	42.83%	26.68K	Jun 07	View
Mar 12, 2024	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-21.03K	$0.67	-$14.09K	SELL	-7.48%	260.17K	Mar 11	View
Mar 12, 2024	Taylor Sandison	CHIEF MEDICAL OFFICER	-20.66K	$0.67	-$13.84K	SELL	-5.62%	347.10K	Mar 11	View
Mar 12, 2024	Shane Ward	COO & CLO	-20.47K	$0.67	-$13.71K	SELL	-9.34%	198.77K	Mar 11	View
Mar 12, 2024	Preetam Shah	CFO & CBO	-18.93K	$0.67	-$12.68K	SELL	-7.69%	227.21K	Mar 11	View
Sep 13, 2023	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-18.47K	$0.95	-$17.51K	SELL	-6.25%	277.19K	Sep 11	View
Sep 13, 2023	Taylor Sandison	CHIEF MEDICAL OFFICER	-18.79K	$0.95	-$17.81K	SELL	-4.91%	363.76K	Sep 11	View
Aug 14, 2023	Leslie Tari	CHIEF SCIENTIFIC OFFICER	10.00K	$0.97	$9.70K	BUY	3.50%	295.66K	Aug 14	View
Aug 08, 2023	Jeffrey Stein	PRESIDENT & CEO	50.00K	$0.96	$47.88K	BUY	15.45%	373.61K	Aug 08	View
Mar 27, 2023	Jeffrey Stein	PRESIDENT & CEO	50.00K	$1.04	$51.85K	BUY	18.27%	323.61K	Mar 27	View
Mar 13, 2023	Shane Ward	COO & CLO	-4.33K	$1.53	-$6.62K	SELL	-4.87%	84.58K	Mar 13	View
Mar 13, 2023	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-7.56K	$1.53	-$11.57K	SELL	-3.80%	191.66K	Mar 13	View
Mar 13, 2023	Preetam Shah	CFO & CBO	-6.65K	$1.53	-$10.17K	SELL	-4.29%	148.14K	Mar 13	View
Mar 13, 2023	Taylor Sandison	CHIEF MEDICAL OFFICER	-7.20K	$1.53	-$11.02K	SELL	-2.44%	288.55K	Mar 13	View
Jan 27, 2023	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-11.81K	$1.20	-$14.18K	SELL	-5.60%	199.22K	Jan 12	View
Sep 19, 2022	Preetam Shah	CFO & CBO	34.36K	$0.77	-$12.03K	SELL-OPTIONS	29.51%	150.79K	Sep 15 - Sep 19	View
Sep 13, 2022	Taylor Sandison	CHIEF MEDICAL OFFICER	-18.48K	$0.68	-$12.66K	SELL	-5.96%	291.75K	Sep 12	View
Sep 13, 2022	Leslie Tari	CHIEF SCIENTIFIC OFFICER	-18.16K	$0.68	-$12.44K	SELL	-8.06%	207.04K	Sep 12	View
Sep 13, 2022	Paul Daruwala	CHIEF OPERATING OFFICER	-16.20K	$0.68	-$11.09K	SELL	-6.83%	221.10K	Sep 12	View
Mar 23, 2022	Brady Johnson	VICE PRESIDENT, FINANCE	-654.00	$0.81	-$529.74	SELL	-1.31%	49.37K	Mar 21	View
Mar 11, 2022	Brady Johnson	VICE PRESIDENT, FINANCE	-945.00	$0.71	-$670.95	SELL	-1.85%	50.02K	Mar 11	View
Jan 07, 2022	Paul Daruwala	CHIEF OPERATING OFFICER	4.77K	$1.25	-$6.42K	SELL-OPTIONS	2.61%	187.30K	Dec 29 - Jan 05	View
Jan 07, 2022	Brady Johnson	VICE PRESIDENT, FINANCE	-154.00	$1.25	-$520.00	SELL	-0.30%	50.97K	Dec 29 - Jan 05	View
Jan 07, 2022	Leslie Tari	CHIEF SCIENTIFIC OFFICER	849.00	$1.25	-$1.56K	SELL-OPTIONS	0.51%	168.70K	Dec 29 - Jan 05	View
Nov 15, 2021	Jeffrey Stein	PRESIDENT & CEO	50.00K	$1.59	$79.53K	BUY	10.92%	507.89K	Nov 12	View
Nov 15, 2021	Preetam Shah	CFO & CBO	20.00K	$1.54	$30.80K	BUY	∞	20.00K	Nov 12	View
Sep 14, 2021	Timothy R Franson	DIRECTOR	7.00K	$2.12	$14.82K	BUY	175.00%	11.00K	Sep 13	View
Aug 19, 2021	Jeffrey Stein	PRESIDENT & CEO	50.00K	$1.74	$86.75K	BUY	12.26%	457.89K	Aug 18 - Aug 19	View
Apr 05, 2021	Neil Abdollahian	CHIEF BUSINESS OFFICER	-837.00	$2.26	-$9.82K	SELL	-1.44%	57.47K	Jan 05 - Apr 01	View
Apr 05, 2021	Paul Daruwala	CHIEF OPERATING OFFICER	-2.06K	$2.16	-$7.49K	SELL	-3.92%	50.53K	Jan 05 - Apr 01	View
Apr 05, 2021	Jessica Oien	GENERAL COUNSEL & SECRETARY	799.00	$2.41	-$4.83K	GRANT	11.47%	7.76K	Jan 05 - Apr 01	View
Nov 12, 2020	Jeffrey Stein	—	50.00K	$2.00	$100.02K	PURCHASE	15.94%	363.59K	Nov 10	View
Nov 12, 2020	James Levine	—	50.00K	$2.01	$100.72K	PURCHASE	75.95%	115.83K	Nov 10	View
Jan 06, 2020	Jessica Oien	—	-834.00	$3.86	-$3.22K	SELL	-10.69%	6.96K	Jan 02	View
Jan 06, 2020	Neil Abdollahian	—	-2.34K	$3.42	-$8.00K	SELL	-4.37%	51.25K	Jan 03	View
Jan 06, 2020	Paul Daruwala	—	-2.34K	$3.42	-$8.00K	SELL	-4.19%	53.53K	Jan 03	View
Oct 03, 2019	Paul Daruwala	CHIEF OPERATING OFFICER	-3.29K	$1.88	-$6.19K	SELL	-5.57%	55.87K	Oct 02	View
Oct 03, 2019	Neil Abdollahian	CHIEF BUSINESS OFFICER	-7.28K	$1.98	-$14.42K	SELL	-12.81%	49.59K	Oct 01	View
Oct 01, 2019	Jessica Oien	GENERAL COUNSEL & SECRETARY	-1.00K	$1.86	-$1.86K	SELL	-11.38%	7.80K	Sep 27	View
Sep 26, 2019	Jeffrey Stein	PRESIDENT & CEO	52.50K	$1.91	$100.10K	BUY	27.80%	241.33K	Sep 24	View
Sep 26, 2019	James Levine	CHIEF FINANCIAL OFFICER	30.00K	$1.91	$57.24K	BUY	17.14%	205.00K	Sep 24	View
Mar 08, 2019	Neil Abdollahian	CHIEF BUSINESS OFFICER	-2.30K	$2.44	-$5.61K	SELL	-7.02%	30.47K	Mar 08	View
Mar 08, 2019	Paul Daruwala	CHIEF OPERATING OFFICER	-2.24K	$2.55	-$5.71K	SELL	-4.32%	49.57K	Mar 07	View
May 24, 2018	Jeffrey Stein	PRESIDENT & CEO	212.77K	$4.70	$1.00M	BUY	380.12%	268.74K	May 23	View
Nov 16, 2017	TARGET BIOTECH V AG BIOTECH BB	10% OWNER	60.00K	$7.57	$453.97K	BUY	2.68%	2.30M	Nov 15	View
Sep 12, 2017	Jeffrey Stein	PRESIDENT & CEO	7.35K	$6.79	$49.91K	BUY	16.36%	52.27K	Sep 12	View
Jun 08, 2017	Taylor Sandison	CHIEF MEDICAL OFFICER	20.00K	$5.90	$118.00K	BUY	351.19%	25.70K	Jun 06 - Jun 07	View
Jun 07, 2017	Jeffrey Stein	PRESIDENT & CEO	15.00K	$5.95	$89.21K	BUY	50.13%	44.92K	Jun 05	View
Apr 04, 2017	Kevin Forrest	CHIEF SCIENTIFIC OFFICER	12.50K	$7.75	$96.88K	BUY	20.88%	72.35K	Mar 31	View
Apr 04, 2017	Jeffrey Stein	PRESIDENT & CEO	12.90K	$7.75	$99.97K	BUY	87.66%	27.62K	Mar 31	View
May 23, 2016	Kevin Forrest	COO & CFO	4.36K	$11.53	$50.22K	BUY	8.08%	58.25K	May 20	View
May 23, 2016	Jeffrey Stein	PRESIDENT & CEO	4.31K	$11.51	$49.61K	BUY	2.04%	215.80K	May 20	View
Nov 27, 2015	Jeffrey Stein	PRESIDENT & CEO	6.70K	$15.09	$101.12K	BUY	3.36%	206.09K	Nov 24 - Nov 25	View
Nov 23, 2015	Kevin Forrest	COO & CFO	7.09K	$14.23	$100.85K	BUY	15.88%	51.72K	Nov 23	View
Apr 22, 2015	Patrick Heron	DIRECTOR	1.31M	$16.00	$3.20M	BUY	∞	291.02K	Apr 20	View
Apr 22, 2015	Nina Kjellson	DIRECTOR	1.36M	$16.00	$3.20M	BUY	∞	1.36M	Apr 20	View
Apr 21, 2015	Jeffrey Stein	PRESIDENT & CEO	420.00	$16.00	$6.72K	BUY	0.21%	199.81K	Apr 20	View
Apr 21, 2015	ROBERT PEREZ	DIRECTOR	5.00K	$16.00	$80.00K	BUY	∞	5.00K	Apr 20	View
Apr 21, 2015	Timothy Franson	DIRECTOR	4.00K	$16.00	$64.00K	BUY	∞	4.00K	Apr 20	View
Apr 21, 2015	DANIEL BURGESS	DIRECTOR	3.00K	$16.00	$48.00K	BUY	∞	3.00K	Apr 20	View

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.